Distinct Profiles of Epigenetic Evolution between Colorectal Cancers with and without Metastasis
Authors:
- 1 April 2011
- journal article
- research article
- Published by Elsevier in The American Journal of Pathology
- Vol. 178 (4) , 1835-1846
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Health, Labor, and Welfare
- Japan Society for the Promotion of Science
- Japanese Society of Gastroenterology
- Sagawa Foundation for Promotion of Cancer Research
- Japan-China Sasakawa Medical Fellowship
This publication has 62 references indexed in Scilit:
- The Role of the CpG Island Methylator Phenotype in Colorectal Cancer Prognosis Depends on Microsatellite Instability Screening StatusClinical Cancer Research, 2010
- Genetic and epigenetic classifications define clinical phenotypes and determine patient outcomes in colorectal cancerBritish Journal of Surgery, 2009
- Hypermethylator Phenotype in Sporadic Colon Cancer: Study on a Population-Based Series of 582 CasesCancer Research, 2008
- CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancerGut, 2008
- Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancerProceedings of the National Academy of Sciences, 2007
- Genetic and epigenetic changes in primary metastatic and nonmetastatic colorectal cancerBritish Journal of Cancer, 2006
- CpG island methylator phenotype in cancerNature Reviews Cancer, 2004
- A molecular signature of metastasis in primary solid tumorsNature Genetics, 2002
- Resection of colorectal liver metastasesWorld Journal of Surgery, 1995
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI: Journal of the National Cancer Institute, 1990